Olfactory dysfunction in COVID‐19, new insights from a cohort of 353 patients: The ANOSVID study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27918
Abstract: Olfactory disorders (OD) pathogenesis, underlying conditions, and prognostic in coronavirus disease 2019 (COVID‐19) remain partially described. ANOSVID is a retrospective study in Nord Franche‐Comté Hospital (France) that included COVID‐19 patients from March 1 2020 to… read more here.
Keywords: olfactory dysfunction; high group; low group; covid new ... See more keywords
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Sign Up to like & getrecommendations! Published in 2020 at "Immunity"
DOI: 10.1016/j.immuni.2020.04.003
Abstract: Summary Zhou et al. (Nature) and Hoffmann et al. (Cell) identify ACE2 as a SARS-CoV-2 receptor, and the latter show its entry mechanism depends on cellular serine protease TMPRSS2. These results may explain proinflammatory cytokine release via the… read more here.
Keywords: receptor; cytokine release; covid new; new virus ... See more keywords
Sleep medicine and COVID-19. Has a new era begun?
Sign Up to like & getrecommendations! Published in 2020 at "Sleep Medicine"
DOI: 10.1016/j.sleep.2020.07.010
Abstract: Abstract Since late December 2019, COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2, has spread rapidly around the world, causing unprecedented changes in provided health care services. Patients diagnosed with sleep-disordered breathing (SDB) are… read more here.
Keywords: medicine; sleep medicine; new era; covid new ... See more keywords
Comments to “Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists” by Khani and Entezari-Maleki
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Psychiatry"
DOI: 10.1038/s41380-022-01546-2
Abstract: after coronavirus-2). A recent systematic review using 57 studies with 250,351 survivors of COVID-19 shows that the median propor- tion of COVID-19 survivors at least 1 PASC (post-acute sequelae of COVID-19) 54% at 1 month… read more here.
Keywords: comments fluvoxamine; term; covid new; fluvoxamine long ... See more keywords
Gut microbiota in COVID-19: new insights from inside
Sign Up to like & getrecommendations! Published in 2023 at "Gut Microbes"
DOI: 10.1080/19490976.2023.2201157
Abstract: ABSTRACT The epidemic of coronavirus disease-19 (COVID-19) has grown to be a global health threat. Gastrointestinal symptoms are thought to be common clinical manifestations apart from a series of originally found respiratory symptoms. The human… read more here.
Keywords: covid new; microbiota; microbiota covid; gut microbiota ... See more keywords
The impact of COVID‐19 on new mesothelioma diagnoses in Italy
Sign Up to like & getrecommendations! Published in 2022 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.14296
Abstract: The aim of this work was to evaluate the impact of the restrictions put in place to control the COVID‐19 pandemic on new diagnoses of malignant mesothelioma (MM) in Italy. read more here.
Keywords: impact covid; mesothelioma diagnoses; mesothelioma; new mesothelioma ... See more keywords
Long COVID: A New Challenge for Prevention of Obesity in Women
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Lifestyle Medicine"
DOI: 10.1177/15598276221111054
Abstract: The long COVID affects individuals that do not recover for several weeks or months following the onset of symptoms of COVID-19. Obesity could play a role in the long COVID syndrome. During the pandemic, various… read more here.
Keywords: obesity women; challenge prevention; covid new; long covid ... See more keywords
The effects of COVID-19 on new oral oncolytic treatments.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.29_suppl.102
Abstract: 102Background: Dependable and timely dispensing and delivery of oral oncolytics to patients with a new indication for therapy is a central part of modern cancer care. The COVID-19 pandemic has pres... read more here.
Keywords: effects covid; oncology; oncolytic treatments; covid new ... See more keywords
Commentary: The psychological and social impact of COVID-19: New perspectives of well-being
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Psychology"
DOI: 10.3389/fpsyg.2022.953147
Abstract: COPYRIGHT © 2022 Flores-Plata, De la Rosa-Gómez, Díaz-Sosa, Valencia-Meléndez and Hernández-Posadas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other… read more here.
Keywords: commentary psychological; covid new; impact covid; psychological social ... See more keywords
SARS-CoV-2 (COVID-19): New Discoveries and Current Challenges
Sign Up to like & getrecommendations! Published in 2020 at "Applied Sciences"
DOI: 10.3390/app10103641
Abstract: SARS-CoV-2 (COVID-19) has today multiplied globally and various governments are attempting to stop the outbreak of the disease escalation into a worldwide health crisis. At this juncture, readiness, candor, clarity, and partaking of data are… read more here.
Keywords: new discoveries; cov covid; current challenges; discoveries current ... See more keywords
Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10051051
Abstract: Peripheral neuropathies constitute a group of disorders affecting the peripheral nervous system. Neuropathies have multiple causes such as infections (i.e., COVID-19), diabetes, and nutritional (low vitamin levels), among others. Many micronutrients, such as vitamins (A,… read more here.
Keywords: covid new; new perspectives; neuropathies derived; treatment ... See more keywords